Q1 roundup of state ag policy impacting biotech
Agricultural legislative activity is proving to be busy this year for biotech as we move out of Q1 and into the summer. GMO labeling, […]
Q1 roundup of state ag policy impacting biotech Read More »
Agricultural legislative activity is proving to be busy this year for biotech as we move out of Q1 and into the summer. GMO labeling, […]
Q1 roundup of state ag policy impacting biotech Read More »
“Data makes you credible; stories make you memorable,” began Amy Niles, Chief Mission Officer of the PAN Foundation, during the Biotechnology Innovation Organization’s (BIO)
Show Me the Evidence: Data to Understand and Break Down Patient Access Barriers! Read More »
April 17 is World Hemophilia Day, and in commemoration, Bio.News sat down to talk with the National Bleeding Disorders Foundation (NBDF) about the importance
World Hemophilia Day: Raising awareness of the need for a cure Read More »
According to a new study, vaccine hesitancy is a deeper issue than the prevalence of misinformation online. Rather, it reflects a deep mistrust in
Eight themes of vaccine hesitancy that could surprise people Read More »
As part of BIO’s March Patient Advocacy Coffee Chat, Thomas Heymann, President & CEO of Sepsis Alliance, spoke about sepsis—a life-threatening condition caused by
Sepsis and AMR: Understanding the connection and the growing threat to public health Read More »
Despite women making up half the population, women’s health has historically been “woefully underfunded,” accounting for less than 5% of products in the biotech
Women’s History Month: What’s the story with women’s health investment? Read More »
The Food and Drug Administration’s (FDA) Rare Pediatric Disease Priority Review Voucher (PPRV) Program was top of mind during BIO’s March Patient Advocacy Coffee
March 8th is International Women’s Day and to mark the occasion, Bio.News is exploring an under researched field of women’s health – autoimmune diseases
International Women’s Day: Improving women’s health by addressing autoimmune disease Read More »
“Kidney disease is a major and growing public health concern,” LaVarne A. Burton, American Kidney Fund President and CEO, said in an interview with
Kidney Action Week: 4 things you need to know about kidney disease Read More »
The Centers for Medicare & Medicaid Services (CMS) recently announced the 2025 selection of 15 drugs covered under Medicare Part D for price “negotiations”
The role of the patient voice in CMS drug price ‘negotiation’ Read More »